Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies
- PMID: 36554382
- PMCID: PMC9778740
- DOI: 10.3390/ijerph192416502
Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies
Abstract
Background: There has not been a review that evaluated the prevalence of multimorbidity in the Middle East. This review aims to measure the prevalence, demographic factors, and consequences of multimorbidity in the Middle East region.
Study design: A quantitative systematic review includes cross-sectional and longitudinal cohort studies.
Methods: The prevalence systematic review approach from the Joanna Briggs Institute was applied. We searched PsychINFO, MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, and the Cochrane Central Register of Controlled Trials. Data were extracted methodically in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards. Studies written in English and released between 2012 and March 2022 were included. For the meta-analysis, a random-effects model was applied. PROSPERO registration number: CRD42022335534.
Results: The final sample consisted of eight cohort and observational studies. The number of participants varied from 354 to 796,427. Multimorbidity was present in all populations with a prevalence of 21.8% (95% confidence interval (CI): 21.7-21.8%).
Conclusion: Multimorbidity affects a significant section of the world's population. A uniform operationalization of multimorbidity is required in the Middle East in order to enable reliable estimates of illness burden, effective disease management, and resource distribution.
Keywords: Middle East; demographics association; multimorbidity; prevalence.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Selenium for preventing cancer.Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Interventions for promoting habitual exercise in people living with and beyond cancer.Cochrane Database Syst Rev. 2018 Sep 19;9(9):CD010192. doi: 10.1002/14651858.CD010192.pub3. Cochrane Database Syst Rev. 2018. PMID: 30229557 Free PMC article.
-
Negative pressure wound therapy for open traumatic wounds.Cochrane Database Syst Rev. 2018 Jul 3;7(7):CD012522. doi: 10.1002/14651858.CD012522.pub2. Cochrane Database Syst Rev. 2018. PMID: 29969521 Free PMC article.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
Cited by
-
Multimorbidity Patterns in the Urban Population in Poland.J Clin Med. 2023 Sep 8;12(18):5860. doi: 10.3390/jcm12185860. J Clin Med. 2023. PMID: 37762801 Free PMC article.
-
Demographic, health, and behaviors profile of Saudi Arabia's aging population 2022-2023.Front Aging. 2025 Feb 26;6:1491146. doi: 10.3389/fragi.2025.1491146. eCollection 2025. Front Aging. 2025. PMID: 40078533 Free PMC article.
-
Perioperative outcomes among older surgical patients with multimorbidity: a longitudinal study from Ethiopia.BMC Public Health. 2025 Aug 4;25(1):2641. doi: 10.1186/s12889-025-24034-y. BMC Public Health. 2025. PMID: 40759940 Free PMC article.
-
Medication adherence in Jordanian patients with multimorbidity: a cross-sectional mixed-methods study in outpatient clinics.Front Pharmacol. 2025 Jul 31;16:1619023. doi: 10.3389/fphar.2025.1619023. eCollection 2025. Front Pharmacol. 2025. PMID: 40822490 Free PMC article.
-
Review of multimorbidity in Saudi Arabia: Prevalence, gender differences, and common chronic diseases.J Multimorb Comorb. 2025 Aug 19;15:26335565251367587. doi: 10.1177/26335565251367587. eCollection 2025 Jan-Dec. J Multimorb Comorb. 2025. PMID: 40842938 Free PMC article. Review.
References
-
- Vetrano D.L., Palmer K., Marengoni A., Marzetti E., Lattanzio F., Roller-Wirnsberger R., Lopez Samaniego L., Rodríguez-Mañas L., Bernabei R., Onder G., et al. Frailty and multimorbidity: A systematic review and meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 2019;74:659–666. doi: 10.1093/gerona/gly110. - DOI - PubMed
-
- The Academy of Medical Sciences . Multimorbidity a Priority for Global Health Research. Academy of Medical Sciences; London, UK: 2018.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources